PhaseBio Pharmaceuticals | NT 10-K: Others
Apr 2 16:24 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Mar 12 16:40 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Nov 29, 2023 16:55 ET
PhaseBio Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Nov 15, 2023 16:17 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Oct 3, 2023 07:17 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Sep 27, 2023 08:52 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Aug 25, 2023 12:34 ET
PhaseBio Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Aug 25, 2023 12:31 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Jun 30, 2023 16:21 ET
PhaseBio Pharmaceuticals | 8-K: Current report
May 30, 2023 16:02 ET
PhaseBio Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
May 16, 2023 16:23 ET
PhaseBio Pharmaceuticals | 8-K: Current report
May 10, 2023 08:08 ET
PhaseBio Pharmaceuticals | NT 10-K: Others
Apr 3, 2023 16:05 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Mar 24, 2023 08:07 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Feb 24, 2023 07:59 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Jan 25, 2023 08:04 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Jan 17, 2023 08:08 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Dec 23, 2022 08:33 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Dec 2, 2022 16:19 ET
PhaseBio Pharmaceuticals | 8-K: Current report
Nov 23, 2022 16:08 ET
No Data
No Data